Crown Electrokinetics Corp.

NasdaqCM:CRKN Stock Report

Market Cap: US$6.3m

Crown Electrokinetics Past Earnings Performance

Past criteria checks 0/6

Crown Electrokinetics's earnings have been declining at an average annual rate of -9.8%, while the Chemicals industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 98.7% per year.

Key information

-9.8%

Earnings growth rate

n/a

EPS growth rate

Chemicals Industry Growth12.9%
Revenue growth rate98.7%
Return on equity-250.0%
Net Margin-228.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Crown ElectroKinetics reports Q2 results

Aug 15

Crown Electrokinetics prices $1M share offering

Jul 20

Crown ElectroKinetics EPS misses by $3.43

Jun 21

Crown ElectroKinetics (CRKN ) Investor Presentation - Slideshow

Jun 14

Loss-Making Crown ElectroKinetics Corp. (NASDAQ:CRKN) Expected To Breakeven In The Medium-Term

Mar 04
Loss-Making Crown ElectroKinetics Corp. (NASDAQ:CRKN) Expected To Breakeven In The Medium-Term

Revenue & Expenses Breakdown

How Crown Electrokinetics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:CRKN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2413-31173
30 Jun 245-28133
31 Mar 241-32132
31 Dec 230-30152
30 Sep 230-22132
30 Jun 230-22123
31 Mar 230-12104
31 Dec 220-14104
30 Sep 220-18135
30 Jun 220-20165
31 Mar 220-21184
31 Dec 210-37193
30 Sep 210-36163
30 Jun 210-36133
31 Mar 210-41164
31 Dec 200-22133
30 Sep 200-21123
30 Jun 200-18123
31 Mar 200-1052
31 Dec 190-952
30 Sep 190-841
30 Jun 190-631
31 Mar 191-421
31 Dec 180-321
31 Mar 180-110

Quality Earnings: CRKN is currently unprofitable.

Growing Profit Margin: CRKN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CRKN is unprofitable, and losses have increased over the past 5 years at a rate of 9.8% per year.

Accelerating Growth: Unable to compare CRKN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CRKN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-0.5%).


Return on Equity

High ROE: CRKN has a negative Return on Equity (-250.04%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies